Given that most ovarian cancers have reduced expression of DDB2 (4) and our current finding that DDB2 enhances TGF-β signaling transduction in ovarian cancer cell lines, we sought to understand whether DDB2 enhances TGF-β-induced ovarian cancer cell growth inhibition. This evidence concerns the gene TGFB1 and ovarian cancer.